Brandon Monk, Head of U.S. Plasma Derived Therapies, Takeda Pharmaceuticals

<p>Brandon Monk, Head of U.S. Plasma Derived Therapies at Takeda Pharmaceuticals, talks about immunizations for and treatment of Covid-19. Takeda is working on a hyperimmune plasma therapy and is a part of the CoVig-19 Plasma Alliance, consisting of top R&D leaders working together for treatment of Covid-19. #financialplanning #retirementreadiness</p>